JESSICA LEWIS: Open Payments
NPI 1770719452 · CHILLICOTHE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$258 in 11 payments from 8 companies in 2025. Trend: 2023 $190 · 2024 $459 · 2025 $258
Food & beverage: $258
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $57 |
| Dexcom, Inc. | 2 | $42 |
| ABBVIE INC. | 2 | $39 |
| Astellas Pharma US Inc | 1 | $31 |
| Merck Sharp & Dohme LLC | 1 | $29 |
| Gilead Sciences, Inc. | 1 | $21 |
| Aimmune Therapeutics, Inc. | 1 | $20 |
| Ardelyx, Inc. | 1 | $20 |
Products named: Kerendia, Dexcom G6 Transmitter, Cresemba, ZERBAXA, DALVANCE, VOWST, IBSRELA, MAVYRET.
Industry payments across OH — which companies pay providers there.
